Relationship between the ability to learn dry-powder inhaler use and the cognitive functions in patients with COPD

Firket Kanat (Konya, Turkey), Baykal Tulek, Nart Bedin Atalay, Ercan Kurtipek, Gulfem Yildirim, Fikret Kanat, Mecit Suerdem

Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections
Session: Novel strategies for the management of asthma, COPD and airway infections
Session type: Thematic Poster Session
Number: 3931
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Firket Kanat (Konya, Turkey), Baykal Tulek, Nart Bedin Atalay, Ercan Kurtipek, Gulfem Yildirim, Fikret Kanat, Mecit Suerdem. Relationship between the ability to learn dry-powder inhaler use and the cognitive functions in patients with COPD. Eur Respir J 2015; 46: Suppl. 59, 3931

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Comparing pharmacist time use for asthma and COPD patients using various types of inhaler devices
Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage?
Year: 2015


Preference, satisfaction and critical errors with Genuair® and Breezhaler® in patients with COPD
Source: International Congress 2014 – Asthma and COPD devices and treatments
Year: 2014


Effects of pharmacist interventions to inhalation medication adherence and lung functions in COPD patients at one stop service clinic
Source: International Congress 2014 – COPD exacerbations
Year: 2014



Improved MDI inhaler technique observed in adult asthma patients with Web based education
Source: Annual Congress 2013 –Improving educational programmes for patients and multidisciplinary healthcare professionals
Year: 2013


The influence of type of inhalation device on adherence of COPD patients to inhaled medication
Source: Annual Congress 2013 –COPD drugs: new findings
Year: 2013


Comparison of asthma and COPD patients' perception of appropriate metered-dose inhaler technique with a questionnaire and supervision based reference standard
Source: International Congress 2014 – Clinical assessment of airway diseases
Year: 2014


Exacerbator subtypes in the tiotropium safety and performance in respimat (TIOSPIR™) trial
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Year: 2014


Differences in adherence to common inhaled medications in COPD
Source: Annual Congress 2013 –COPD drugs: new findings
Year: 2013


Pharmacokinetics, safety and tolerability of CHF5993 a triple pMDI in renal impaired patients
Source: International Congress 2016 – Novel avenues in the treatment of COPD I
Year: 2016


Glycopyrronium significantly improves lung function, dyspnea and health status in COPD patients in all GOLD groups
Source: International Congress 2015 – New data on established treatments for asthma and COPD
Year: 2015

Comparison of inspiratory flow rates using an innovative dry powder inhaler (DPI) in patients with mild–severe asthma and severe COPD
Source: International Congress 2014 – Rationale behind respiratory drug development
Year: 2014

Validation of a new inhaled therapeutic algorithm for the stable COPD patient: The COPD easy treatment project
Source: International Congress 2015 – Management of COPD and other respiratory diseases in primary care
Year: 2015


Local effect of airway clearance techniques in COPD patients
Source: International Congress 2014 – Physical activity, exercise and physiotherapy in patients with COPD
Year: 2014

LATE-BREAKING ABSTRACT: Glycopyrronium once-daily significantly improves lung function and health status when added to fluticasone/salmeterol in patients with COPD: The GLISTEN study
Source: International Congress 2014 – Latest insights in airway diseases
Year: 2014

Demonstration skills and knowledge for inhalers use are lacking among NCHD and nurses
Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders
Year: 2013


Once-daily QVA149 improves dyspnoea, lung function and reduces rescue medication use in symptomatic patients with COPD using LAMA as prior medication: The BLAZE study
Source: International Congress 2014 – Clinical trials of drugs and biomarkers for respiratory diseases
Year: 2014


Practical aspects of inhaler therapy in frail elderly patients
Source: Eur Respir Mon; 2009: 43: 256–266
Year: 2009

The patient’s role in the choice of new inhaler devices and dosing regimens for asthma and COPD: A preference study
Source: International Congress 2016 – Kaleidoscope of respiratory nursing
Year: 2016


Distribution and outcomes of the new Spanish phenotype-based guideline for COPD
Source: International Congress 2014 – COPD exacerbations
Year: 2014

Assessment of the bioequivalence of two DPIs containing fluticasone and salmeterol, in patients with controlled or partly controlled asthma
Source: International Congress 2016 – Clinical characteristics of asthma
Year: 2016